aod9604 what is it AOD-9604 AOD-9604 Vial (10mg) | High-Purity

A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human

[DOI] [PubMed] [Google Scholar] 252.Joshi, P

An FDA-approved peptide, AOD 9604, has been proven to help with weight loss

Two Phase 2 trials were conducted concurrently: one in adults with obesity without diabetes, published in the New England Journal of Medicine in June 2023, and one in adults with type 2 diabetes, published simultaneously in The Lancet

Optimized Protocol for Selective Fat Metabolism Dosing: Starting dose: 250 mcg per day (subcutaneous injection) Standard dose: 300-500 mcg per day after 1-2 weeks Frequency: Once daily or divided into two doses (morning and early afternoon) Administration: Route: Subcutaneous injection (abdomen, thigh, or upper arm) Timing: Morning fasted state ideal, or 30-60 minutes before cardio Storage: Reconstituted peptide refrigerated, typically stable 30-60 days Cycle Length: 12-16 weeks for initial assessment, with potential for extended protocols based on clinical trial data showing safe use up to 24 weeks

This isnt about treating a medical issue, but about optimizing your health